ESOTERICA  DAYTIME WITH MOISTURIZERS AND SUNSCREEN - hydroquinone, oxybenzone and padimate o cream 
Medicis Pharmaceutical Corp

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredientsPurpose
Hydroquinone USP 2%Skin Lightener
Oxybenzone USP 2.5%Sunscreen
Padimate O USP 3.3%Sunscreen

Use

Lightens dark (brownish) areas on the skin such as freckles, age and liver spots, pigment in skin that may occur in pregnancy or from the use of oral contraceptives. Contains a sunscreen to help prevent darkening from reoccurring.

Warnings

For external use only.

Do not use:

  • On inflamed or broken skin
  • For prevention of sunburn
  • As sunscreen
  • On children under 12 years of age unless directed by a physician

Ask a doctor or pharmacist before use if you are taking products containing resorcinol, phenol, or salicylic acid

When using this product:

  • Avoid contact with eyes
  • Mild skin irritation may occur. If skin irritation becomes severe, stop use and consult a doctor
  • Limit sun exposure

If pregnant or breast-feeding, ask a healthcare professional before use.

Keep out of reach of children. If swallowed get medical help or contact a poison control center right away.

Directions

Adults

  • Apply a small amount as a thin layer to affected areas twice daily or as directed by a doctor
  • For sensitive skin, test overnight on small area (inside elbow)
  • If no improvement is seen after 3 months of treatment, discontinue use. On very dark skin, lightening effect may not be noticeable
  • Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring.

Other information

Inactive ingredients

purified water USP, isopropyl myristate NF, stearyl alcohol NF, glyceryl stearate and sodium lauryl sulfate NF, propylene glycol USP, ozokerite, poloxamer 188, steareth-20, ceteareth-3, fragrance, dimethicone, sodium metabisulfite NF, methylparaben NF, propylparaben NF, sodium lauryl sulfate NF, butylated hydroxyanisole NF, anhydrous citric acid USP, trisodium EDTA

Questions?

1-800-900-6389 (24 hours a day, 7 days a week)

Distributed by:
MEDICIS
The Dermatology Company®
Scottsdale, AZ 85256

PRINCIPAL DISPLAY PANEL - 70 g Carton

Skin Lightener with Moisturizers and Sunscreen
NDC # 99207-291-02

E
ESOTÉRICA®

ESOTÉRICA®
FADE CREAM

DAYTIME
With Moisturizers
and Sunscreen

Net Wt.
2.5 oz (70 g)

Principal Display Panel - 70 g Carton

ESOTERICA   DAYTIME WITH MOISTURIZERS AND SUNSCREEN
hydroquinone, oxybenzone, and padimate o cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:99207-291
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
hydroquinone (hydroquinone) hydroquinone20 mg  in 1 g
oxybenzone (oxybenzone) oxybenzone25 mg  in 1 g
padimate o (padimate o) padimate o33 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
water 
isopropyl myristate 
stearyl alcohol 
glyceryl monostearate 
sodium lauryl sulfate 
propylene glycol 
ceresin 
poloxamer 188 
steareth-20 
dimethicone 
sodium metabisulfite 
methylparaben 
propylparaben 
butylated hydroxyanisole 
anhydrous citric acid 
edetate trisodium 
Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:99207-291-021 JAR ( JAR) in 1 CARTONcontains a JAR
170 g in 1 JARThis package is contained within the CARTON (99207-291-02)

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart358A06/01/2005

Labeler - Medicis Pharmaceutical Corp (182837492)
Establishment
NameAddressID/FEIOperations
Contract Pharmaceutical Limited248761249MANUFACTURE

Revised: 06/2011 Medicis Pharmaceutical Corp